Viking’s $350M offering; Baker Brothers leads another PIPE

Plus, news about Applied Therapeutics, Beam Therapeutics, Janux Therapeutics and more:

Viking Therapeutics sells off $350M of stock following positive obesity drug data: On the same day that Viking shared positive topline data for its “double G” GLP-1/GIP receptor agonist that could compete with Eli Lilly’s Zepbound, the company Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks